US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review
Executive Summary
The FDA has overruled the results from its own formula intended to match resource levels with workload every time except once.
You may also be interested in...
New Workload Categories Add To FDA Staff Needs, Help Increase User Fees
Postmarketing activities, such as REMS document and annual report reviews, are now part of the formula used to account for workload changes in user fee calculations, which likely helped push fees higher in fiscal year 2024.
New Translational Science Team Created In US FDA’s CDER To Aid Rare Disease Drug Development
The group is intended to help rare disease drug developers answer all the necessary questions about surrogate endpoints and markers before the application review cycle.
US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.